Gene · 8554
Papers1,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells. | Cells | 2023 | 37887350 | PubTator, text mining | PubMed |
| Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC. | Aging (Albany NY) | 2023 | 37870748 | PubTator, text mining | PubMed |
Evaluation of the relations between reproduction-related pituitary and ovarian hormones and abdominal fat area-related variables determined with computed tomography in overweight or obese women who have undergone bariatric surgery: a cross-sectional study. | Quant Imaging Med Surg | 2023 | 37869350 | PubTator, text mining | PubMed |
| The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37867531 | PubTator, text mining | PubMed |
| Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma. | Front Cell Dev Biol | 2023 | 37860820 | PubTator, text mining | PubMed |
| A Cell-Penetrant Peptide Disrupting the Transcription Factor CP2c Complexes Induces Cancer-Specific Synthetic Lethality. | Adv Sci (Weinh) | 2023 | 37845006 | PubTator, text mining | PubMed |
| Estrogen Receptor Signaling in Breast Cancer. | Cancers (Basel) | 2023 | 37835383 | PubTator, text mining | PubMed |
| PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs. | Int J Mol Sci | 2023 | 37833942 | PubTator, text mining | PubMed |
| Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells. | J Transl Med | 2023 | 37833712 | PubTator, text mining | PubMed |
| Double-strand DNA break repair: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37808268 | PubTator, text mining | PubMed |
| Unraveling the Complex Interplay between Epigenetics and Immunity in Alcohol-Associated Liver Disease: A Comprehensive Review. | Int J Biol Sci | 2023 | 37781509 | PubTator, text mining | PubMed |
| A CK2 and SUMO-dependent, PML NB-involved regulatory mechanism controlling BLM ubiquitination and G-quadruplex resolution. | Nat Commun | 2023 | 37777511 | PubTator, text mining | PubMed |
| Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells. | Cell | 2023 | 37774705 | PubTator, text mining | PubMed |
| Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. | Int J Mol Sci | 2023 | 37762066 | PubTator, text mining | PubMed |
| The Molecular and Function Characterization of Porcine MID2. | Animals (Basel) | 2023 | 37760252 | PubTator, text mining | PubMed |
| ERα promotes SUMO1 transcription by binding with the ERE and enhances SUMO1-mediated protein SUMOylation in breast cancer. | Gland Surg | 2023 | 37727335 | PubTator, text mining | PubMed |
| A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease. | bioRxiv | 2023 | 37693487 | PubTator, text mining | PubMed |
| SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition. | J Biol Chem | 2023 | 37690680 | PubTator, text mining | PubMed |
| SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells. | Aging (Albany NY) | 2023 | 37683133 | PubTator, text mining | PubMed |
| The emerging roles of SUMOylation in pulmonary diseases. | Mol Med | 2023 | 37670258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/papers?page=6